Biocon Ltd. announced on March 24, 2025, that its subsidiary, Biocon Pharma, received approval from the U.S. Food and Drug Administration (USFDA) for its ANDA (Abbreviated New Drug Application) of Norepinephrine Bitartrate Injection USP. The injection is used to raise blood pressure in adult patients experiencing acute hypotension. The approved product is a 4 mg/4 …